Skip to main content
SpringerLink
Log in

Nutritional Factors, Oxidative Stress and Lung Transplantation

  • Chapter
  • First Online:
Inflammatory Response in Cardiovascular Surgery

  • 1312 Accesses

Abstract

Transplantation is the only treatment of choice for end-stage lung disease patients. This procedure is labor-intensive, expensive, and driven by the availability of organ donation. Considering the ongoing significant organ donor shortage, it is important to ensure that each transplant candidate will survive and achieve the maximum long-term outcome. Unfortunately, there are still challenging long-term complications associated with lung transplant recipients, and research is ongoing to maximize medical treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hertz MI, Taylor DO, Trulock EP, Boucek MM, Mohacsi PJ, Edwards LB, et al. The registry of the international society for heart and lung transplantation: nineteenth official report—2002. J Heart Lung Transplant. 2002;21(9):950–70.

    Article  PubMed  Google Scholar 

  2. Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, Jones DR, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg. 2002;73(4):1041–8.

    Article  PubMed  Google Scholar 

  3. Hertz MI. Immunosuppression for prevention of bronchiolitis obliterans. Curr Opin Transpl. 2000;5(4):402–6.

    Article  Google Scholar 

  4. Jungraithmayr W, Draenert A, Marquardt K, Weder W. Ultrastructural changes in acute lung allograft rejection: novel insights from an animal study. J Heart Lung Transplant. 2012;31(1):94–100.

    Article  PubMed  Google Scholar 

  5. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo TG, et al. Obliterative bronchiolitis after lung and heart-lung transplantation. J Thorac Cardiovasc Surg. 1995;110(1):4–14.

    Article  PubMed  CAS  Google Scholar 

  6. El-Gamel A, Sim E, Hasleton P, Hutchinson J, Yonan N, Egan J, et al. Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant. 1999;18(9):828–37.

    Article  PubMed  CAS  Google Scholar 

  7. Girgis RE, Tu I, Berry GJ. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant. 1996;15:1200–8.

    PubMed  CAS  Google Scholar 

  8. Jain R, Hachem RR, Morrell MR, Trulock EP, Chakinala MM, Yusen RD, et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant. 2010;29(5):531–7.

    Article  PubMed  Google Scholar 

  9. Vos R, Vanaudenaerde BM, Ottevaere A, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, et al. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer? J Heart Lung Transplant. 2010;29(12):1358–68.

    Article  PubMed  Google Scholar 

  10. DiGiovine B, Lynch JP, Matinez FJ, Flint A, Whyte RI, Iannettoni M, et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol. 1996;157:4194–202.

    PubMed  CAS  Google Scholar 

  11. Snyder L, Ash C, Jackson W, Howel D, Willner DA, Palmer S. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med. 2010;181:1391–6.

    Article  PubMed  Google Scholar 

  12. Madill J, Aghdassi E, Arendt B, Gutierrez C, Chow CW, Hartman-Craven B, et al. Lung transplantation: does oxidative stress contribute to the development of bronchiolitis obliterans syndrome? Transplant Rev. 2009;23(2):103–10.

    Article  Google Scholar 

  13. Chabot F, Mitchell JA, Gutteridge JMC, Evans T. Reactive oxygen species in acute lung injury. Eur Respir J. 1998;11:745–57.

    PubMed  CAS  Google Scholar 

  14. Sies H. Oxidative stress: introduction. In: Sies H, ed. Oxidative stress: oxidants and antioxidants. San Diego: Academic; 1991. p. xv–xxii.

    Google Scholar 

  15. Kregel K, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological consideration. Am J Physiol Regul Integr Comp Physiol. 2007;292:R18–36.

    Article  PubMed  CAS  Google Scholar 

  16. Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull. 1993;49(566):576.

    Google Scholar 

  17. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000;71(2):621S–9.

    PubMed  CAS  Google Scholar 

  18. Gonzalez-Flecha B. Oxidant mechanisms in response to ambient air particles. Mol Aspects Med. 2004;25:169–82.

    Article  PubMed  CAS  Google Scholar 

  19. Houglum K, Bedossa P, Chojkier M. TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am J Physiol. 1994;267(5 Pt 1):G908–13.

    PubMed  CAS  Google Scholar 

  20. Houglum K, Filip M, Witztum JL, Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest. 1990;86(6):1991–8.

    Article  PubMed  CAS  Google Scholar 

  21. Heyland D, Dhaliwal R, Suchner U, Berber MM. Antioxidant nutrients: a systematic review or trace elements and vitamins in the critically ill patient. Intensive Care Med. 2005;31:327.

    Article  PubMed  Google Scholar 

  22. Barrera G, Pizzimenti S, Dianzani MU. Lipid peroxidation: control of cell proliferation, cell differentiation and cell death. Mol Aspects Med. 2008;29(1–2):1–8.

    Article  PubMed  CAS  Google Scholar 

  23. van der Vliet A. NADPH oxidases in lung biology and pathology: host defense enzymes, and more. Free Radic Biol Med. 2008;44(6):938–55.

    Article  PubMed  CAS  Google Scholar 

  24. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr. 1993;57(suppl):715S–25.

    PubMed  CAS  Google Scholar 

  25. Tabassum H, Parvez S, Rehman H, Banerjee BD, Raisuddin S. Catechin as an antioxidant in liver mitochondrial toxicity: inhibition of tamoxifen-induced protein oxidation and lipid peroxidation. J Biochem Mol Toxicol. 2007;21(3):110–7.

    Article  PubMed  CAS  Google Scholar 

  26. Kayali R, Cakatay U, Tekeli F. Male rats exhibit higher oxidative protein damage than females of the same chronological age. Mech Ageing Dev. 2007;128(5–6):365–9.

    Article  PubMed  CAS  Google Scholar 

  27. Collins A, Cadet J, Epe B, Gedik C. Problems in the measurement of 8-oxoguanine in human DNA. Report of a workshop, DNA oxidation, held in Aberdeen, UK, 19–21 January, 1997. Carcinogenesis. 1997;18(9):1833–6.

    Article  PubMed  CAS  Google Scholar 

  28. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003;17(10):1195–214.

    Article  PubMed  CAS  Google Scholar 

  29. Madill J, Aghdassi E, Arendt BM, Gutierrez C, Singer L, Chow C, et al. Oxidative stress and nutritional intakes in lung patients with bronchiolitis obliterans syndrome. Transplant Proc. 2009;41(9): 3838–44.

    Article  PubMed  CAS  Google Scholar 

  30. Williams A, Riise G, Anderson B, Kjellström C, Scherstén H, Kelly F. Compromised antioxidant status and persistent oxidative stress in lung transplant recipients. Free Radic Res. 1999;30:383–93.

    Article  PubMed  CAS  Google Scholar 

  31. Stephenson A, Brotherwood M, Robert R, Durie P, Verjee Z, Chaparro C, et al. Increased vitamin A and E levels in adult cystic fibrosis patients after lung transplantation. Transplantation. 2005;79(5):613–5.

    Article  PubMed  CAS  Google Scholar 

  32. Heymsfield SB. How large is the energy gap that accounts for the obesity epidemic? Am J Clin Nutr. 2009;89(6):1717–8.

    Article  PubMed  CAS  Google Scholar 

  33. Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T. Oxidative stress and metabolic syndrome in obese adults with and without controlled diet restriction. Bratisl Lek Listy. 2009;110(3):152–7.

    PubMed  CAS  Google Scholar 

  34. Esposito K, Ciotola M, Giugliano D. Mediterranean diet, endothelial function and vascular inflammatory markers. Public Health Nutr. 2006;9(8A):1073–6.

    Article  PubMed  Google Scholar 

  35. Egger G, Dixon J. Non-nutrient causes of low-grade, systemic inflammation: support for a ‘canary in the mineshaft’ view of obesity in chronic disease. Obes Rev. 2011;12(5):339–45.

    Article  PubMed  CAS  Google Scholar 

  36. Dietrich M, Jialal I. The effect of weight loss on stable biomarker of inflammation, C-reactive protein. Nutr Rev. 2005;63(1):22–8.

    Article  PubMed  Google Scholar 

  37. Wu B, Fukuo K, Suzuki K, Yoshino G, Kazumi T. Relationships of systemic oxidative stress to body Fat distribution, adipokines and inflammatory markers in healthy middle-aged women. Endocr J. 2009;56(6):773–82.

    Article  PubMed  CAS  Google Scholar 

  38. de Mattos AM, Shibagaki Y, Russo K, Rivinus A, Prather J, Markovich A, et al. Study 2: relationship between pretransplant obesity and posttransplant cardiovascular events, diabetes mellitus, and graft and patient survival in renal transplant recipients. Transplant Rev. 2003;17(4):S38.

    Article  Google Scholar 

  39. Thuluvath PJ. Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation. Liver Transpl. 2007;13(12):1627–9.

    Article  PubMed  Google Scholar 

  40. Williams JJ, Lund LH, LaManca J, Kunavarapu C, Cohen DJ, Heshka S, et al. Excessive weight gain in cardiac transplant recipients. J Heart Lung Transplant. 2006;25(1):36–41.

    Article  PubMed  Google Scholar 

  41. Aalten J, Christiaans MH, de Fijter H, Hené R, Homan van der Heijde J, Roodnat J, et al. The influence of obesity on short- and long-term graft and patient survival after renal transplantation. Transpl Int. 2006;19(11):901–7.

    Article  PubMed  Google Scholar 

  42. Kanasky Jr WF, Anton SD, Rodrigue JR, Perri MG, Szwed T, Baz MA. Impact of body weight on long-term survival after lung transplantation. Chest. 2002;121(2):401–6.

    Article  PubMed  Google Scholar 

  43. Culver DA, Mazzone PJ, Khandwala F, Blazey HC, DeCamp MM, Chapman JT. Discordant utility of ideal body weight and body mass index as predictors of mortality in lung transplant recipients. J Heart Lung Transplant. 2005;24(2):137–44.

    Article  PubMed  Google Scholar 

  44. Madill J, Gutierrez C, Grossman J, Allard J, Chan C, Hutcheon M, et al. Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90–day mortality following transplantation. J Heart Lung Transplant. 2001;20(3):288–96.

    Article  PubMed  CAS  Google Scholar 

  45. Singer LG, Brazelton TR, Doyle RL, Morris RE, Theodore J. Weight gain after lung transplantation. J Heart Lung Transplant. 2003;22(8):894–902.

    Article  PubMed  Google Scholar 

  46. Halliwell B. Free radicals and antioxidants: a personal view. Nutr Rev. 1994;52(8):253–65.

    Article  PubMed  CAS  Google Scholar 

  47. Wood L, Fitzgerald D, Gibson P, Cooper D, Collins C, Garg M. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr. 2001;20(2):157–65.

    Article  PubMed  CAS  Google Scholar 

  48. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients. Am J Clin Nutr. 2002;75(4):668–75.

    PubMed  CAS  Google Scholar 

  49. Wood LG, Fitzgerald DA, Garg ML. Hypothesis: vitamin E complements polyunsaturated fatty acids in essential fatty acid deficiency in cystic fibrosis. J Am Coll Nutr. 2003;22:253–7.

    Article  PubMed  CAS  Google Scholar 

  50. Wood LG, Fitzgerald DA, Lee AK, Garg ML. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr. 2003;77(1):150–9.

    PubMed  CAS  Google Scholar 

  51. Papas KA, Sontag MK, Pardee C, Sokol RJ, Sagel SD, Accurso FJ, et al. A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis. J Cyst Fibros. 2008;7(1):60–7.

    Article  PubMed  CAS  Google Scholar 

  52. Shahar E, Folsom AR, Melnick SL, Tockman MS, Comstock GW, Gennaro V, et al. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N Engl J Med. 1994;331(4):228–34.

    Article  PubMed  CAS  Google Scholar 

  53. Schwartz J. Role of polyunsaturated fatty acid in lung disease. Am J Clin Nutr. 2000;71(suppl):397s–406.

    Google Scholar 

  54. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med. 1991;91:14S–22.

    Article  PubMed  CAS  Google Scholar 

  55. Anderson BM, Ma D. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis. 2009;8(33):1–20.

    Google Scholar 

  56. Matsuyama W, Mitsuyama H, Watanabe M, Oonakahara K, Higashimoto I, Osame M, et al. Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD. Chest. 2005;128(6): 3817–27.

    Article  PubMed  CAS  Google Scholar 

  57. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000;71(1(suppl)):343S–8.

    PubMed  CAS  Google Scholar 

  58. Clinical Practice Guidelines on Growth and Nutrition Subcommittee, Ad Hoc Working Group, Stallings VA, Stark LJ, Robinson KA, Feranchak AP, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008;108(5):832–9.

    Article  PubMed  Google Scholar 

  59. McKarney C, Everard M, N’Diaye T. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev. 2007;(4):CD002201.

    Google Scholar 

  60. Durieu I, Vericel E, Guichardant D, Roth H, Steghens JP, Drai J, et al. Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: an open pilot observational study. J Cyst Fibros. 2007;6(5):320–6.

    Article  PubMed  CAS  Google Scholar 

  61. Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev. 2001;23:268–71.

    Article  PubMed  CAS  Google Scholar 

  62. Romieu I, Meneses F, Ramirez M, Ruiz S, Perez A, Padilla R, et al. Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone. Am J Respir Crit Care Med. 1998;158:226–32.

    Article  PubMed  CAS  Google Scholar 

  63. Kelly F. Vitamins an respiratory disease: antioxidant micronutrients in pulmonary health an disease. Proc Nutr Soc. 2005;64:510–26.

    Article  PubMed  CAS  Google Scholar 

  64. Niki E, Noguchi N, Tsuchihashi H, Gotoh N. Interaction among vitamin C, vitamin E, and beta-carotene. Am J Clin Nutr. 1995;62(6):1322S.

    PubMed  CAS  Google Scholar 

  65. Herbert V. Prooxidant effects of antioxidant vitamins: introduction. J Nutr. 1996;126:1197S–200.

    PubMed  CAS  Google Scholar 

  66. Romieu I. Nutrition and lung health [State of the Art]. Int J Tuberc Lung Dis. 2005;9(4):362–74.

    PubMed  CAS  Google Scholar 

  67. Miedema I, Feskens E, Heederik D, Kromhout D. Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The zutphen study. Am J Epidemiol. 1993;138(1):37–45.

    PubMed  CAS  Google Scholar 

  68. Carey IM, Strachan DP, Cook DG. Effects of changes in fresh fruit consumption on ventilatory function in healthy British adults. Am J Respir Crit Care Med. 1998;158:728–33.

    Article  PubMed  CAS  Google Scholar 

  69. Butland BK, Fehily AM, Elwood PC. Diet, lung function decline in a cohort of 2512 middle aged men. Thorax. 2000;55:102–8.

    Article  PubMed  CAS  Google Scholar 

  70. McKeever T, Scrivener S, Broadfield E, Jones Z, Britton J, Lewis S. Prospective study of diet and decline in lung function in a general population. Am J Respir Crit Care Med. 2002;165:1299–303.

    Article  PubMed  Google Scholar 

  71. Varraso R, Fung TT, Barr RG, Hu FB, Willett W, Camargo Jr CA. Prospective study of dietary patterns and chronic obstructive pulmonary disease among US women. Am J Clin Nutr. 2007;86(2):488–95.

    PubMed  CAS  Google Scholar 

  72. Schünemann H, Freudenheim J, Grant B. Epidemiologic evidence linking antioxidant vitamins to pulmonary function and airway obstruction. Epidemiol Rev. 2001;23(2):248–67.

    Article  PubMed  Google Scholar 

  73. Cao G, Booth S, Sadowski J, Prior R. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruits and vegetables. Am J Clin Nutr. 1998;68:1081–7.

    PubMed  CAS  Google Scholar 

  74. Britton JR, Pavord ID, Richards KA, Knox AJ, Wisniewski AF, Lewis SA, et al. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med. 1995;151:1383–7.

    Article  PubMed  CAS  Google Scholar 

  75. Schwartz J, Weiss ST. Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES I). Am J Clin Nutr. 1994;59:110–4.

    PubMed  CAS  Google Scholar 

  76. Grievink L, Smit H, Ocké M, Van ’t Veer P, Kromhout D. Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN study. Thorax. 1998;53:166–71.

    Article  PubMed  CAS  Google Scholar 

  77. Tujague J, Bastaki M, Holland N, Balmes JR, Tager IB. Antioxidant intake, GSTM1 polymorphism and pulmonary function in healthy young adults. Eur Respir J. 2006;27(2):282–8.

    Article  PubMed  CAS  Google Scholar 

  78. Morabia AA, Soreenson A, Kumanyika SK, Abbey H, Cohen BH, Chee E. Vitamin A, cigarette smoking and airway obstruction. Am Rev Respir Dis. 1989;140:1312–6.

    Article  PubMed  CAS  Google Scholar 

  79. McKeever TM, Britton J. Diet and asthma. Am J Respir Crit Care Med. 2004;170:725–9.

    Article  PubMed  Google Scholar 

  80. Chuwers P, Barnhart S, Blanc P, Brodkin CA, Cullen M, Kelly T, et al. The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort. Am J Respir Crit Care Med. 1997;155:1066–71.

    Article  PubMed  CAS  Google Scholar 

  81. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the third national health and nutrition examination survey (NHANES III). Am J Epidemiol. 2000;151(10):975–81.

    Article  PubMed  CAS  Google Scholar 

  82. The ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol. 1994;4(1):1–10.

    Google Scholar 

  83. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029–35.

    Article  Google Scholar 

  84. Omenn G. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future. Eur J Cancer Prev. 2007;16(3):184–91.

    Article  PubMed  CAS  Google Scholar 

  85. Riise GC, Williams A, Kjellstrom C, Schersten H, Andersson BA, Kelly FJ. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung. Eur Respir J. 1998;12(1):82–8.

    Article  PubMed  CAS  Google Scholar 

  86. Kelly F, Mudway I, Blomberg A, Frew A, Sandstrom T. Altered lung antioxidant status in patients with mild asthma. Lancet. 1999;354:482–3.

    Article  PubMed  CAS  Google Scholar 

  87. Schock B, Young I, Brown V, Fitch P, Shields M. Antioxidants and oxidative stress in BAL fluid of atopic asthmatic children. Pediatr Res. 2002;53(3):375–81.

    Article  Google Scholar 

  88. Portal B, Richard M, Faure H, Hadjian A, Favier A. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr. 1995;61(4):843–7.

    PubMed  CAS  Google Scholar 

  89. Back EI, Frindt C, Nohr D, Frank J, Ziebach R, Stern M, et al. Antioxidant deficiency in cystic fibrosis: when is the right time to take action? Am J Clin Nutr. 2004;80:374–84.

    PubMed  CAS  Google Scholar 

  90. Renner S, Rath R, Rust P, Lehr S, Frischer T, Elmadfa I, et al. Effects of β-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax. 2001;56:48–52.

    Article  PubMed  CAS  Google Scholar 

  91. Bowler RP, Velsor LW, Duda B, Chan ED, Abraham E, Ware LB, et al. Pulmonary edema fluid antioxidants are depressed in acute lung injury. Crit Care Med. 2003;31(9):2309–15.

    Article  PubMed  CAS  Google Scholar 

  92. Thomson MJ, Puntmann V, Kaski JC. Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment? Cardiovasc Drugs Ther. 2007;21:195–210.

    Article  PubMed  CAS  Google Scholar 

  93. Boothby LA, Doering PL. Vitamin C and vitamin E for Alzheimer’s disease. Ann Pharmaocother. 2005;39(12):2073–80.

    Article  CAS  Google Scholar 

  94. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2008;(2):CD007176.

    Google Scholar 

  95. Bjelakovic G. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297(8):842–57.

    Article  PubMed  CAS  Google Scholar 

  96. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37–46.

    Article  PubMed  CAS  Google Scholar 

  97. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians’ health study II randomized controlled trial. JAMA. 2008;300(18):2123–33.

    Article  PubMed  CAS  Google Scholar 

  98. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet. 2003;361(9374):2017–23.

    Article  PubMed  CAS  Google Scholar 

  99. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334(18):1145–9.

    Article  PubMed  CAS  Google Scholar 

  100. Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians’ health study II randomized controlled trial. JAMA. 2009;301(1):52–62.

    Article  PubMed  CAS  Google Scholar 

  101. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2009;301(1):39–51.

    Article  PubMed  CAS  Google Scholar 

  102. Heinecke JW. Is the emperor wearing clothing? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol. 2001;21:1261–4.

    Article  PubMed  CAS  Google Scholar 

  103. Berger MM. Can oxidative damage be treated nutritionally? Clin Nutr. 2005;24(2):172–83.

    Article  PubMed  CAS  Google Scholar 

  104. Lampe JW. Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies. Am J Clin Nutr. 1999;70(3):475S–90.

    PubMed  CAS  Google Scholar 

  105. Pellegrini N, Salvatore S, Valtuena S, Bedogni G, Porrini M, Pala V, et al. Development and validation of a food frequency questionnaire for the assessment of dietary total antioxidant capacity. J Nutr. 2007;137(1):93–8.

    PubMed  CAS  Google Scholar 

  106. Pellegrini N, Serafini M, Salvatore S, Del Rio D, Bianchi M, Brighenti F. Total antioxidant capacity of spices, dried fruits, nuts, pulses, cereals and sweets consumed in Italy assessed by three different in vitro assays. Mol Nutr Food Res. 2006;50(11):1030–8.

    Article  PubMed  CAS  Google Scholar 

  107. Pellegrini N, Serafini M, Colombi B, Del Rio D, Salvatore S, Bianchi M, et al. Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J Nutr. 2003;133(9):2812–9.

    PubMed  CAS  Google Scholar 

  108. Pellegrini N, Riso P, Porrini M. Tomato consumption does not affect the total antioxidant capacity of plasma. Nutrition. 2000;16(4):268–71.

    Article  PubMed  CAS  Google Scholar 

  109. Brighenti F, Valtuena S, Pellegrini N. Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects. Br J Nutr. 2005;93(5):619–25.

    Article  PubMed  CAS  Google Scholar 

  110. di Giuseppe R, Arcari A, Serafini M, Di Castelnuovo A, Zito F, De Curtis A, et al. Total dietary antioxidant capacity and lung function in an Italian population: a favorable role in premenopausal/never smoker women. Eur J Clin Nutr. 2012;66:61–8.

    Article  PubMed  CAS  Google Scholar 

  111. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr. 2005;81:215S–7.

    PubMed  CAS  Google Scholar 

  112. Meyers DG, Maloley PA, Weeks D. Safety of antioxidant vitamins. Arch Intern Med. 1996;156(9):925–35.

    Article  PubMed  CAS  Google Scholar 

  113. Krinsky HI. Human requirements for fat-soluble vitamins, and other things concerning these nutrients. Mol Aspects Med. 2003;24:317.

    Article  PubMed  CAS  Google Scholar 

  114. Halliwell B. Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. Nutr Rev. 1999;57(4):104–13.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brescia University College, Western University, London, Ontario

    Janet Madill PhD, RD (Assistant Professor)

  2. Lung Transplant Program, University of Toronto, Toronto, ON, Canada

    Chung-Wai Chow MD

  3. Department of Medicine, University Health Network (UHN), Toronto, ON, Canada

    Bianca Arendt PhD & Johane Allard MD

Authors
  1. Janet Madill PhD, RD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bianca Arendt PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chung-Wai Chow MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Johane Allard MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janet Madill PhD, RD .

Editor information

Editors and Affiliations

  1. University Nove de Julho, Melo Alves 685, São Paulo, 01417-010, São Paulo, Brazil

    Edmo Atique Gabriel

  2. Pontifícia Universidade Católica de Camp, Rodovia D. Pedro I, km 136, São Paulo, 13086-900, São Paulo, Brazil

    Sthefano Atique Gabriel

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Madill, J., Arendt, B., Chow, CW., Allard, J. (2013). Nutritional Factors, Oxidative Stress and Lung Transplantation. In: Gabriel, E., Gabriel, S. (eds) Inflammatory Response in Cardiovascular Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-4429-8_48

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4429-8_48

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4428-1

  • Online ISBN: 978-1-4471-4429-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation